Molecular monitoring of lung allograft health: is it ready for routine clinical use?

"Conflict of interest: P. Pradère, A. Zajacova, and J. Le Pavec have no conflict of interest to declare. S. Bos has received lecture fees from Therakos (Mallinckrodt) and Jazz, and conference registration/travel support from GlaxoSmithKline and Takeda, outside the submitted work. A. Fisher has received research grant income to his institution from Chiesi Pharmaceuticals, Pfizer, Therakos (Mallinckrodt) and GlaxoSmithKline. He has received consultancy fees via his institution from Sanofi and Altavant and speaker fees from Therakos (Mallinckrodt). All of the above are for activities outside the submitted work."

"Support statement: P. Pradère is supported by the Groupe Hospitalier Paris Saint Joseph as a visiting research fellow to Newcastle University. S. Bos is supported by the Paul Corris International Clinical Research Training Scholarship at Newcastle University. A. Fisher is supported by the National Institute for Health and Care Research (NIHR) Blood and Transplant Research Unit in Organ Donation and Transplantation (NIHR203332), a partnership between NHS Blood and Transplant, University of Cambridge and Newcastle University. The views expressed are those of the author(s) and not necessarily those of the NIHR, NHS Blood and Transplant or the Department of Health and Social Care."